179 related articles for article (PubMed ID: 17371461)
1. Metabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated GH deficiency due to a GHRH receptor mutation.
Gleeson H; Barreto ES; Salvatori R; Costa L; Oliveira CR; Pereira RM; Clayton P; Aguiar-Oliveira MH
Clin Endocrinol (Oxf); 2007 Apr; 66(4):466-74. PubMed ID: 17371461
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin and body composition in children with familial GH deficiency (GHD) due to a mutation in the growth hormone-releasing hormone (GHRH) receptor.
de A Barretto ES; Gill MS; De Freitas ME; Magalhães MM; Souza AH; Aguiar-Oliveira MH; Clayton PE
Clin Endocrinol (Oxf); 1999 Nov; 51(5):559-64. PubMed ID: 10594516
[TBL] [Abstract][Full Text] [Related]
3. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
Rizzo M; Trepp R; Berneis K; Christ ER
Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
[TBL] [Abstract][Full Text] [Related]
4. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
[TBL] [Abstract][Full Text] [Related]
5. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance.
Galimov A; Hartung A; Trepp R; Mader A; Flück M; Linke A; Blüher M; Christ E; Krützfeldt J
J Mol Med (Berl); 2015 Dec; 93(12):1369-79. PubMed ID: 26199111
[TBL] [Abstract][Full Text] [Related]
7. Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation.
Menezes Oliveira JL; Marques-Santos C; Barreto-Filho JA; Ximenes Filho R; de Oliveira Britto AV; Oliveira Souza AH; Prado CM; Pereira Oliveira CR; Pereira RM; Ribeiro Vicente Tde A; Farias CT; Aguiar-Oliveira MH; Salvatori R
J Clin Endocrinol Metab; 2006 Jun; 91(6):2093-9. PubMed ID: 16522693
[TBL] [Abstract][Full Text] [Related]
8. Lipid profiles in untreated severe congenital isolated growth hormone deficiency through the lifespan.
Gleeson HK; Souza AH; Gill MS; Wieringa GE; Barretto ES; Barretto-Filho JA; Shalet SM; Aguiar-Oliveira MH; Clayton PE
Clin Endocrinol (Oxf); 2002 Jul; 57(1):89-95. PubMed ID: 12100075
[TBL] [Abstract][Full Text] [Related]
9. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
[TBL] [Abstract][Full Text] [Related]
10. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
[TBL] [Abstract][Full Text] [Related]
11. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
[TBL] [Abstract][Full Text] [Related]
12. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
13. Effects of depot growth hormone replacement on thyroid function and volume in adults with congenital isolated growth hormone deficiency.
Leite NT; Salvatori R; Alcântara MR; Alcântara PR; Oliveira CR; Oliveira JL; Anjos-Andrade FD; Farias MI; Britto CT; Nóbrega LM; Nascimento AC; Alves ÉO; Pereira RM; Campos VC; Menezes M; Martinelli CE; Aguiar-Oliveira MH
J Endocrinol Invest; 2012 Mar; 35(3):265-8. PubMed ID: 21422802
[TBL] [Abstract][Full Text] [Related]
14. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls.
Li Voon Chong JS; Groves T; Foy P; Wallymahmed ME; MacFarlane IA
Clin Endocrinol (Oxf); 2002 Feb; 56(2):175-81. PubMed ID: 11874408
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone and the risk of atherosclerosis in growth hormone-deficient children.
Binay C; Simsek E; Yıldırım A; Kosger P; Demiral M; Kılıç Z
Growth Horm IGF Res; 2015 Dec; 25(6):294-7. PubMed ID: 26296621
[TBL] [Abstract][Full Text] [Related]
16. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
17. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
18. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
[TBL] [Abstract][Full Text] [Related]
19. Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome.
Murray RD; Wieringa GE; Lissett CA; Darzy KH; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 2002 Apr; 56(4):525-32. PubMed ID: 11966746
[TBL] [Abstract][Full Text] [Related]
20. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.
Li Voon Chong JS; Benbow S; Foy P; Wallymahmed ME; Wile D; MacFarlane IA
Clin Endocrinol (Oxf); 2000 Nov; 53(5):551-9. PubMed ID: 11106915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
